R. Mark Adams, PhD.
R. Mark Adams has been in the field of
bioinformatics for more than 10 years with extensive experience
in the design and implementation of large-scale informatics systems,
including regulated systems for use in clinical trials and the management
of high- throughput laboratory processes. Additionally, his academic
work has encompassed abstract mathematical and computational analysis of
molecular genetic and protein structure. His scientific work has resulted
in many patent applications, with several patents granted. As a
biotechnology executive Mark has extensive experience in the strategic
leadership and management of scientific and technical teams, having managed
teams of up to 50 biologists and computer scientists designing and
implementing high-throughput molecular biology and bioinformatics systems.
In his role as vice-president of the public biotechnology company,
Variagenics (now Nuvelo,) Mark
served on the executive committee, chartered with creating and executing a
strategic plan for cancer pharmacogenomics.
Mark earned his Ph.D. in cell
biology at Baylor College of Medicine
in Houston, TX. His postdoctoral work with Temple Smith at the
Biomolecular Engineering Research Center focused on computational protein
functional determination. He is also an active member of the field of
bioinformatics where he speaks and publishes frequently. He is also
an editor of the journals Briefings in Bioinformatics and
Applied Analytics in Consulting.
- Interests Include:
- Molecular Biology
- Biological Computer Simulations
- Artificial Life
- Paper Models
See my obituary page for William S. Burroughs here.
Mark can be reached via email at: